CAR NK-cell therapy (GI Cell/HK inno.N)

N/A

Report date: 2025/03/14 16:47:59

Base Information

Drug NameCAR NK-cell therapy (GI Cell/HK inno.N)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulantsNatural killer cells stimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGi Cell Inc

China Registration ClassN/A

Develop Information

Active CompaniesCartexell Inc Gi Cell Inc HK Inno N Corp

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A